Advertisement
Outsourcing
Subscribe to Outsourcing

The Lead

Entrepreneurial Spirit

April 22, 2014 3:19 pm | by Mike Auerbach, Editor in Chief | Articles | Comments

PCI, Inc. a contract manufacturing and research organization based in Newburyport, MA that develops and manufactures NCEs, generic APIs and fine chemicals has grown from a small start-up to a company that can now take a product all the way from development to commercial production in a smooth and seamless process for its clients.

AMRI Closing Syracuse-Area Lab in July

April 17, 2014 11:33 am | News | Comments

Albany Molecular Research Inc. announced Wednesday that it will close its 12-year-old facility...

UPM to Manufacture Generic Commercial Products for Amerigen Pharmaceuticals

April 2, 2014 1:44 pm | News | Comments

UPM, a division of Gregory Pharmaceutical Holdings, Inc., has reached an agreement with Amerigen...

High-Potency Product Manufacturing - Key Selection Criteria When Evaluating an Outsourcing Partner

March 27, 2014 11:32 am | White Papers

Approximately 25% of drugs in development worldwide are classified as highly potent, with this...

View Sample

FREE Email Newsletter

Flexible Packaging - Growth and Flexibility Make Reed-Lane a Valuable Packaging Partner

March 27, 2014 9:07 am | by Mike Auerbach, Editor-in Chief | Articles | Comments

No two packaging projects are alike and in order to make it all work and to keep everything on track and everyone happy you need to have a flexible, responsive and quality-driven organizations. Reed-Lane has deftly combined these qualities along with recent investments to create a truly flexible contract packaging operation.

Catalent Increases Stake in Redwood Bioscience

March 24, 2014 10:48 am | News | Comments

Catalent Pharma Solutions today announced that based on compelling data generated by the SMARTag™ ADC platform, it has increased its minority investment in Redwood Bioscience.             

AMRI to Acquire Cedarburg Pharmaceuticals

March 24, 2014 7:58 am | News | Comments

AMRI has signed a definitive agreement to acquire all the outstanding shares of Cedarburg Pharmaceuticals, Inc. for $38.2 million in cash. The transaction, including $2.8 million of assumed liabilities, is valued at $41 million.     

Advertisement

Charles River Labs to Acquire Galapagos NV CRO Services Division

March 13, 2014 8:18 am | News | Comments

Charles River Laboratories International, has entered into a definitive agreement to acquire the CRO services division of Galapagos NV, which includes both Argenta and BioFocus.            

Pharmaceutical Processing's March 2014 Digital Edition

March 12, 2014 11:19 am | Digital Editions | Comments

The March issue of Pharmaceutical Processing is our INTERPHEX 2014 show issue and features numerous highlights from show exhibitors. In addition, we also announce the winners in our new Facility Excellence Awards program.

Clinipace Worldwide Acquires Choice Pharma - Expands into Asia

March 11, 2014 11:09 am | News | Comments

With the merger, the company extends its global footprint to include 20 operational offices in 15 countries, including new offices in Taiwan, China, Hong Kong, South Korea, Vietnam, Singapore, and Malaysia.       

WuXi PharmaTech and Pacific Biomarkers Announce Collaboration

March 11, 2014 8:12 am | News | Comments

In a new agreement, PBI will provide access to its extensive menu of validated biomarker assays to support WuXi's integrated clinical trial testing services. This includes bioanalysis and central laboratory services for pharmaceutical and biotech companies performing clinical drug development in China.

Almac Expands Asia Pacific Operations, Establishes Regional Operations Centre in Singapore

March 11, 2014 8:03 am | News | Comments

Almac has announced the expansion of its clinical services and technologies capabilities to include on-the-ground leadership as well as technical, project and operational resources in Asia. The company has established regional hubs in Singapore and Japan to better enable the industry’s growing need to conduct clinical trials in Asia and/or manage global trials from the region.

Advertisement

Progenitor Cell Therapy Announces Bi-Coastal Facility Expansions

March 10, 2014 8:33 am | News | Comments

Progenitor Cell Therapy has expanded both its Allendale, NJ and Mountain View, CA current Good Manufacturing Practice facilities to significantly increase its engineering and process development laboratories, and controlled environment space available for client needs.

Outsourcing to the Emerging Markets

March 7, 2014 11:24 am | by Bikash Chatterjee, President and CTO, Pharmatech Associates | Articles | Comments

The movement toward transparency is global, touching almost every aspect of society. Whether the topic is NSA eavesdropping in the U.S. or banking practices in the European Union, transparency and accountability go hand in hand. The pharma industry is no different.

Norwich Recognized for Equipment Investments

March 3, 2014 12:59 pm | by Jeff Reinke; @JeffReinkeABM | Articles | Comments

The Norwich Pharma Services manufacturing facility in Norwich, New York is as varied in its capabilities as it is its equipment investment strategy. This dedication to growth through equipment and technology investment has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.

Custom Processing Services Recognized for Excellence in Manufacturing

March 3, 2014 12:45 pm | by Jeff Reinke; @JeffReinkeABM | Articles | Comments

Custom Processing Services has a strong track record of contract manufacturing in the pharmaceuticals marketplace. And on November 11, 2011 that legacy was strengthened with the opening of a 42,000 square foot facility dedicated to GMP processing, with two unique GMP processing stations. This commitment has led to it being recognized as one of Pharmaceutical Processing’s Facility Excellence Award winners for 2014.

Pharmaceutical Processing Announces 2014 Facility Excellence Award Winners

March 3, 2014 12:15 pm | by Jeff Reinke; @JeffReinkeABM | Articles | Comments

New development technologies, expanded contract manufacturing and service capabilities, as well as innovative equipment investment strategies highlight leading practices from the best in pharmaceutical processing comprise the 2014 Pharmaceutical Processing Facility Excellence Award winners.

Advertisement

Olympus Biotech Selling New Hampshire Biopharmaceutical Manufacturing Facility

March 3, 2014 11:40 am | News | Comments

Olympus Biotech today announced the initiation of an aggressive transaction process to find a buyer of its West Lebanon, NH manufacturing facility over the next 90 days. In recent months, the Company has received interest from buyers and contract manufacturing organization (CMO) partners, but no deal has been consummated yet.

Pharmaceutical Processing's January/February 2014 Digital Edition

February 28, 2014 10:42 am | Digital Editions | Comments

The Jan/Feb 2014 issue of Pharmaceutical Processing is our INTERPHEX 2014 Preview issue and features numerous exhibitor highlights and a guide to the educational conference program. In addition, we profile Xcelience, a clinical trial material contract manufacturer based in Tampa, FL.

CMO/CSO Roundtable

January 28, 2014 3:50 pm | by Mike Auerbach, Editor in Chief | Articles | Comments

Pharmaceutical Processing's Editor In Chief Mike Auerbach discusses current and future outsourcing trends with a select group of companies.                  

Mayne Pharma USA Names New President

January 28, 2014 11:42 am | News | Comments

Mayne Pharma Group Limited has named Stefan Cross as president of Mayne Pharma USA. Cross is responsible for leading all of Mayne Pharma’s existing business operations in the United States, and for spearheading new business development initiatives.

Full Service CDMO

January 22, 2014 3:34 pm | Product Releases | Comments

Metrics Inc. is a full-service global CDMO. Our expertise includes FTIM formulations, Phases I-III CTM manufacturing and analytical support services leading to commercial manufacturing. 

Lyophilization CMO

January 22, 2014 1:55 pm | Product Releases | Comments

LSNE is a CMO with a proven regulatory history, specializing in process development, aseptic fill/finish and lyophilization. No matter what stage of development you are in, our development team can partner with you to optimize your manufacturing process.

Sterile Injectables CMO

January 22, 2014 11:45 am | Product Releases | Comments

OSO BioPharmaceuticals Manufacturing LLC is a CMO that delivers injectable sterile liquid, suspension and lyophilized biologic and pharmaceutical products to the pharmaceutical industry.

Unique Pharmaceuticals Registers as Outsourcing Facility with FDA

January 20, 2014 3:54 pm | News | Comments

Unique Pharmaceuticals, Ltd. has voluntarily registered with the U.S. Food and Drug Administration (FDA) as a Human Drug Compounding Outsourcing Facility following guidance from the recently enacted Drug Quality and Security Act.   

SP Scientifc to Supply AAIPharma with New Lyophilizers

January 16, 2014 10:35 am | News | Comments

SP Scientific and AAIPharma Services Corp. have entered into a purchase agreement where SP will supply AAIPharma with a LyoStar 3 pilot-scale lyophilizer paired with a complementing Hull production-scale lyophilizer, both equipped with Praxair’s ControLyo™ Nucleation On-Demand Technology. 

CCBR-SYNARC and BioClinica Announce Merger

January 16, 2014 8:29 am | News | Comments

CCBR-SYNARC and BioClinica, Inc. have signed an agreement to merge their companies to create a global provider of specialized outsourced clinical services. The combined company will offer a portfolio of services uniquely tailored to conducting and managing global clinical trials on behalf of the world's premier pharmaceutical and biotechnology companies.

Excellence Achieved

January 14, 2014 11:45 am | by Mike Auerbach, Editor in Chief | Articles | Comments

 A focus on core competencies allows Xcelience to deliver clinical trial materials with speed, efficiency and quality.                                                

AAIPharma Completes Parenteral Manufacturing Facility Expansion

January 14, 2014 11:13 am | News | Comments

AAIPharma Services a provider of pharmaceutical analytical testing, product development and manufacturing services, announced today that it has completed a multi-million dollar expansion of its cGMP parenteral manufacturing facility in Charleston, S.C.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading